Wednesday, February 19, 2020 11:05:00 AM
Meeting on SATURDAY APRIL 18TH @ 1PM IN WASHINGTON DC. There's the MGM Harbor Casino though NWBO is out of Bethesda so doubt they'd swing around to the other side of the beltway.
Very interesting doing this on a Saturday, thinking they want as much retail there as they can get.
NW Bio Announces Annual Shareholders' Meeting Scheduled for April 18, 2020
9:15 am ET February 18, 2020 (PR Newswire) Print
Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax(R) personalized immune therapies for solid tumor cancers, announced today that the 2019 Annual Shareholder's Meeting will be held on April 18, 2020, at 1:00 pm in Washington, DC.
https://mma.prnewswire.com/media/325355/northwest_biotherapeutics__inc__logo.jpg
The Company encourages shareholders to attend what should be an interesting meeting. This announcement is being made to allow shareholders time to make necessary travel plans to come to Washington. The proxy information and other materials will be forwarded to shareholders in an official mailing at a later date.
The Company looks forward to seeing all who can attend.
I added nicely in the low .16's. MAYBE they'll have data lock and top line by then??????????????????????
NWBO GGOES BALLISTIC!!! .16's to the BIG $$$
Anything can happen in BIOLAND.
Very interesting doing this on a Saturday, thinking they want as much retail there as they can get.
NW Bio Announces Annual Shareholders' Meeting Scheduled for April 18, 2020
9:15 am ET February 18, 2020 (PR Newswire) Print
Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax(R) personalized immune therapies for solid tumor cancers, announced today that the 2019 Annual Shareholder's Meeting will be held on April 18, 2020, at 1:00 pm in Washington, DC.
https://mma.prnewswire.com/media/325355/northwest_biotherapeutics__inc__logo.jpg
The Company encourages shareholders to attend what should be an interesting meeting. This announcement is being made to allow shareholders time to make necessary travel plans to come to Washington. The proxy information and other materials will be forwarded to shareholders in an official mailing at a later date.
The Company looks forward to seeing all who can attend.
I added nicely in the low .16's. MAYBE they'll have data lock and top line by then??????????????????????
NWBO GGOES BALLISTIC!!! .16's to the BIG $$$
Anything can happen in BIOLAND.
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
